AHIA
IDXX icon

Andrew Hill Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Andrew Hill Investment Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$997K Buy
1,893
+1,331
+237% +$747K 0.74% 35
2026
Q1 		$316K Sell
562
-9
-2% -$5.77K 0.28% 47
2025
Q4 		$387K Buy
571
+75
+15% +$51.1K 0.29% 38
2025
Q3 		$317K Sell
496
-3
-0.6% -$1.82K 0.25% 42
2025
Q2 		$268K Sell
499
-1
-0.2% -$478 0.22% 47
2025
Q1 		$210K Sell
500
-12
-2% -$5.21K 0.2% 43
2024
Q4 		$212K Sell
512
-2,155
-81% -$945K 0.16% 49
2024
Q3 		$1.35M Sell
2,667
-229
-8% -$111K 1.01% 31
2024
Q2 		$1.41M Sell
2,896
-771
-21% -$387K 1.17% 29
2024
Q1 		$1.98M Buy
3,667
+59
+2% +$32.2K 1.75% 29
2023
Q4 		$2M Buy
+3,608
New +$1.69M 2.09% 26
2022
Q2 		– Sell
-2,889
Closed -$1.58M – 50
2022
Q1 		$1.58M Buy
2,889
+710
+33% +$373K 1.75% 23
2021
Q4 		$1.43M Buy
+2,179
New +$1.37M 1.34% 25

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Andrew Hill Investment Advisors's IDXX Position: Q2 2026 in Review

Andrew Hill Investment Advisors increased its Idexx Laboratories (IDXX) stake by 237% in Q2 2026, buying an estimated $747K and bringing the position to 1,893 shares worth $997K. The position accounts for 0.74% of the portfolio, ranked #35.

Andrew Hill Investment Advisors first reported a position in IDXX in Q4 2021 and has held it in 13 quarters since. The position peaked at $2M in Q4 2023. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Andrew Hill Investment Advisors held 1,893 shares of Idexx Laboratories worth $997K as of Q2 2026.
  • Andrew Hill Investment Advisors bought 1,331 Idexx Laboratories shares in Q2 2026, an estimated $747K.
  • Idexx Laboratories made up 0.74% of Andrew Hill Investment Advisors's portfolio in Q2 2026, its #35 holding.
  • Andrew Hill Investment Advisors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 13 quarters since.
  • Andrew Hill Investment Advisors's Idexx Laboratories position peaked at $2M in Q4 2023.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Andrew Hill Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.